BeStock  
Markets › Compare › IMVT vs QLYS

IMVT vs QLYS

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
IMVT · Immunovant$33.25 ▼ 1.10%
QLYS · Qualys$198.68 ▲ 2.94%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

47108169231292Oct 7, '25Apr 7, '26Oct 5, '26
  • IMVT +106.4%
  • QLYS +55.6%

Head to head

MetricIMVTQLYS
Price$33.25$198.68
Change today▼ 1.10%▲ 2.94%
Market cap$6.87B$6.87B
Return, 3 months-17.1%+26.1%
Return, year to date+30.8%+49.5%
Return, 1 year+100.9%+53.3%
P/E (TTM)-11.834.5
P/B9.312.2
P/E percentile vs own 5y––
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)2764
30-day volatility33.5%67.6%
Max drawdown, 1 year-26.0%-50.5%
Trend readLeaning bearishStrong uptrend
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • QLYS is the largest of the group by market value.
  • IMVT has returned the most over the past year.
  • IMVT carries the lowest trailing P/E.
  • IMVT has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top